medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Número 3

<< Anterior Siguiente >>

Rev Invest Clin 2016; 68 (3)


HLA risk haplotype: insulin deficiency in pediatric Type 1 diabetes

Gómez-Díaz RA, Nishimura-Meguro E, Garrido-Magaña E, Lizárraga PL, Aguilar HBE, Bekker-Méndez C, Medina SR, Barquera R, Mondragón-González R, Wacher NH

Idioma: Ingles.
Referencias bibliográficas: 36
Paginas: 128-136
Archivo PDF: 89.40 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Erlich H, Valdes AM, Noble J, et al. Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the Type 1 Diabetes Genetics Consortium families. Diabetes. 2008;57:1084-92.

  2. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes. 1984;33:176-83.

  3. Nistico L, Buzzetti R, Pritchard LE, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet. 1996;5:1075-80.

  4. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet. 2004;36:337-8.

  5. Vella A, Cooper JD, Lowe CE, et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet. 2005;76:773-9.

  6. Hakonarson H, Grant SF, Bradfield JP, et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature. 2007;448:591-4.

  7. Valdes AM, Erlich HA, Carlson J, Varney M, Moonsamy PV, Noble JA. Use of class I and class II HLA loci for predicting age at onset of type 1 diabetes in multiple populations. Diabetologia. 2012; 55:2394-401.

  8. Rodríguez-Ventura AL, Yamamoto-Furusho JK, Coyote N, et al. HLA-DRB1*08 allele may help to distinguish between type 1 diabetes mellitus and type 2 diabetes mellitus in Mexican children. Pediatr Diabetes. 2007;8:5-10.

  9. Gómez-Díaz RA, Garibay-Nieto N, Wacher-Rodarte N, Aguilar- Salinas CA. Epidemiology of type 1 diabetes in Latin America. Curr Diabetes Rev. 2014;10:75-85.

  10. Collado-Mesa F, Barceló A, Arheart KL, Messiah SE. An ecological analysis of childhood-onset type 1 diabetes incidence and prevalence in Latin America. Rev Panam Salud Publica. 2004;15:388-94.

  11. Gorodezky C, Alaez C, Murguía A, et al. HLA and autoimmunity diseases: Type 1 diabetes (T1D) as an example. Autoimmun Rev. 2006;5:187-94.

  12. Erlich HA, Zeidler A, Chang J, et al. HLA class alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Gen. 1993;3:358-64.

  13. Dorman JS, McCarthy B, McCanlies E, et al. Molecular IDDM epidemiology: international studies. WHO DiaMond Molecular Epidemiology Sub-Project Group. Diabetes Res Clin Pract. 1996; 34(Suppl 1):S107-16.

  14. Cruz-Tapias P, Pérez-Fernández OM, Rojas-Villarraga AR, Rodríguez- Rodríguez A, Arango MT, Anaya JM. Shared HLA Class II in six autoimmune diseases in Latin America: A meta-analysis. Autoimmune Dis. 2012;2012:569728 doi: 10.1155/2012/569728.

  15. Gorodezky C, Olivo A, Debaz H, et al. Inmunogenética de la diabetes mellitus tipo 1 en poblaciones mestizas de México, Colombia y Venezuela. In: Municio AM and García Barreno P (eds). Polimorfismo Génico (HLA) en Poblaciones Hispanoamericanas. Madrid: Publicaciones de la Real Academia de Ciencias Exactas, Físicas y Naturales, 1996:215-31.

  16. Santos JL, Pérez-Bravo F, Carrasco E, Calvillán M, Albala C. Association between HLA-DQB1 alleles and type 1 diabetes in a case-parents study conducted in Santiago, Chile. Am J Epidemiol. 2001;153:794-8.

  17. Mimbacas A, Pérez-Bravo F, Hidalgo PC, et al. Association between diabetes type 1 and DQB1 alleles in a case-control study conducted in Montevideo, Uruguay. Genet Mol Res. 2003;2:29-35.

  18. Redondo MJ, Kawasaki E, Mulgrew CL, et al. DR- and DQassociated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602. J Clin Endocrinol Metab. 2000;85:3793-7.

  19. Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia. 2006;49:881-90.

  20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Supp l):S81-90.

  21. Gorodezky C, Alaez C, Vázquez-García MN, et al. The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol. 2001;62:979-91.

  22. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference, Vol. 1 In: Tsuji K, Aizawa M, Sasazuki T (eds). Tokyo, Japan: Oxford University Press. 1992:1065-74.

  23. Excoffier L, Laval G, Schneider S. Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online. 2005;1:47-50.

  24. Zuñiga J, Yu N, Barquera R, et al. HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLOS One. 2013;8:e74442.

  25. Pérez F, Calvillán M, Santos JL, Carrasco E. Insulin-dependent diabetes mellitus in Santiago, Chile: the role of immunogenetic and environmental factors. Rev Med Chil. 1996;124:1177-86.

  26. Kiani J, Hajilooi M, Furst D, et al. HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population. Int J Immunogenet. 2015;42:279-86.

  27. Tuomilehto J. The emerging global epidemic of type 1 diabetes. Curr Diab Rep. 2013;13:795-804.

  28. Gillespie KM, Gale EA, Bingley PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes. 2002; 51:210-4.

  29. Aly TA, Ide A, Jahromi MM, et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA. 2006;103:14074-9.

  30. Greenwood BM. Autoimmune disease and parasitic infections in Nigerians. Lancet. 1968;2:380-2.

  31. Alarcón GS, McGwin G, Petri M, et al. PROFILE Study Group Baseline characteristics of a multiethnic lupus cohort: profile. Lupus. 2002;11:95-101.

  32. McKeigue PM. Prospects for admixture mapping of complex traits. Am J Hum Genet. 2005;76:1-7.

  33. Easton DF. Linkage analysis and genetic models for IDDM. Genet Epidemiol. 1989;6:83-8.

  34. Gillespie KM, Aitken RJ, Wilson AJ, Williams AJ, Bingley PJ. Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings. Diabetes. 2014;63: 1041-7.

  35. Howson JM, Stevens H, Smyth DJ, et al. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes. 2011;60: 2635-44.

  36. Long AE, Gillespie KM, Rokni S, Bingley PJ, Williams AJ. Rising incidence of type 1 diabetes is associated with altered immunophenotype at diagnosis. Diabetes. 2012;61:683-6.




2020     |     www.medigraphic.com